Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19

2020514 citationslettergreen Open Access

Authors

Funder: \n Bundesministerium für Bildung und Forschung\n https://doi.org/10.13039/501100002347

Good health and well-being

Published in: Antimicrobial Agents and Chemotherapy

Volume 64, Issue 6

Field-Weighted Citation Impact: 12.01